Paul J Moberg

Author PubWeight™ 65.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006 3.02
2 Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr Bull 2009 2.98
3 An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia. Am J Psychiatry 2008 2.53
4 Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord 2014 2.30
5 Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement 2012 2.13
6 Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 2004 2.00
7 Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2008 1.92
8 Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 2003 1.71
9 Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord 2011 1.57
10 The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration. Arch Clin Neuropsychol 2004 1.57
11 Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2008 1.49
12 Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cogn Behav Neurol 2004 1.34
13 Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord 2005 1.32
14 Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol 2003 1.30
15 Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 2010 1.29
16 Facial emotion perception in depression and bipolar disorder: a quantitative review. Psychiatry Res 2011 1.27
17 Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011 1.26
18 Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 2010 1.20
19 Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005 1.15
20 Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study. Schizophr Bull 2005 1.13
21 Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry 2003 1.09
22 Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull 2009 1.08
23 Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology 2002 1.04
24 Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry 2003 1.03
25 Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry 2003 1.03
26 Dimensions of executive function in Parkinson's disease. Dement Geriatr Cogn Disord 2005 0.97
27 Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J Biol Psychiatry 2011 0.96
28 Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatry Clin Neurosci 2006 0.95
29 Computerized neurocognitive test performance in schizophrenia: a lifespan analysis. Am J Geriatr Psychiatry 2012 0.95
30 Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies. Schizophr Bull 2010 0.94
31 Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 2007 0.93
32 Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism Relat Disord 2006 0.90
33 Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. Schizophr Res 2002 0.89
34 Normative data for the symbol cancellation test in young healthy adults. Appl Neuropsychol 2004 0.88
35 Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology 2008 0.87
36 Identification of pleasant, neutral, and unpleasant odors in schizophrenia. Psychiatry Res 2011 0.87
37 Medication management and neuropsychological performance in Parkinson's disease. Clin Neuropsychol 2011 0.86
38 Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia. Schizophr Res 2007 0.86
39 Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res 2008 0.85
40 Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel. Assessment 2004 0.83
41 The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord 2010 0.83
42 Olfaction and schizophrenia clinical risk status: just the facts. Schizophr Res 2012 0.83
43 Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull 2011 0.83
44 The TCN/AACN 2010 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists. Clin Neuropsychol 2011 0.82
45 Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology 2004 0.81
46 Verbal learning and memory in older adults with minor and major depression. Arch Clin Neuropsychol 2011 0.81
47 Relationship between clock-drawing and neuropsychological and functional status in elderly institutionalized patients with schizophrenia. Am J Geriatr Psychiatry 2003 0.80
48 The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth. J Psychiatr Res 2013 0.80
49 Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia? Schizophr Res 2009 0.79
50 The TCN/AACN 2005 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists. Clin Neuropsychol 2006 0.78
51 Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults. Aging Ment Health 2013 0.78
52 Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia. Behav Neurosci 2011 0.77
53 Association between facial emotion recognition and odor identification in schizophrenia. J Neuropsychiatry Clin Neurosci 2007 0.77
54 Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker. Psychiatry Res 2012 0.76
55 An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis. Schizophr Res 2012 0.75
56 The influence of semantic processing on odor identification ability in schizophrenia. Arch Clin Neuropsychol 2013 0.75